See All Slides - tctmd.com

Slides

Presentation

Platelet Responsiveness to Clopidogrel Treatment After Peripheral Endovascular Procedures

Presenter: Stavros Spiliopoulos

April 25, 2013

Presentation TCTAP 2013

Transcatheter Aortic Valve Implantation in Patients with an Annulus Dimension Suitable for either the Edwards Valve or the CoreValve

Presenter: Yusuke Watanabe

April 25, 2013

Presentation TCTAP 2013

Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-Eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry

Presenter: Jung-Min Ahn

April 25, 2013

Presentation TCTAP 2013

How to Choose TAVI or SAVR

Presenter: I. Sheiban

April 25, 2013

Presentation TCTAP 2013

TAVI Technology and Procedural Changes

Presenter: Eberhard Grube

April 25, 2013

Presentation TCTAP 2013

The Fate of PCI for Multi-Vessel Disease From COURAGE to Syntax

Presenter: Seung-Jung Park

April 24, 2013

Presentation

Intracoronary Injection of Bone Marrow Derived Mononuclear Cells, Early or Late After AMI

Presenter: D. S?rder

April 24, 2013

Presentation TCTAP 2013

Controversies: TAVI is Preferred in All High-Risk Patients

Presenter: Alain Cribier

April 24, 2013

Presentation TCTAP 2013

No More Device, Lack of Evidence

Presenter: Ted Feldman

April 24, 2013

Presentation TCTAP 2013

Resisting the Bioabsorble Stent Bandwagon: A Healthy Dose of Skepticism

Presenter: David J. Cohen

April 24, 2013

Advertisement

Slides

Platelet Responsiveness to Clopidogrel Treatment After Peripheral Endovascular Procedures

Transcatheter Aortic Valve Implantation in Patients with an Annulus Dimension Suitable for either the Edwards Valve or the CoreValve

Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-Eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry

How to Choose TAVI or SAVR

TAVI Technology and Procedural Changes

The Fate of PCI for Multi-Vessel Disease From COURAGE to Syntax

Intracoronary Injection of Bone Marrow Derived Mononuclear Cells, Early or Late After AMI

Controversies: TAVI is Preferred in All High-Risk Patients

No More Device, Lack of Evidence

Resisting the Bioabsorble Stent Bandwagon: A Healthy Dose of Skepticism

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content